Glaxo Wellcome House
Records under this name other than patents Glaxo Wellcome House holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Glaxo Wellcome House
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,552,404 | Opioid compounds and methods for using same Formerly held Term ended Term ended no later than Sep 3, 2016 · Low confidence | Term ended | Term ended no later than Sep 3, 2016 | Low confidence |
| US 5,574,159 | Opioid compounds and methods for making therefor Formerly held Term ended Term ended no later than Nov 12, 2016 · Low confidence | Term ended | Term ended no later than Nov 12, 2016 | Low confidence |
| US 5,658,908 | Opioid diarylmethylpiperazines and piperdines Formerly held Term ended Term ended no later than Aug 19, 2017 · Low confidence | Term ended | Term ended no later than Aug 19, 2017 | Low confidence |
| US 5,681,830 | Opioid compounds Formerly held Term ended Term ended no later than Oct 28, 2017 · Low confidence | Term ended | Term ended no later than Oct 28, 2017 | Low confidence |